Cargando…
Design and implementation of an adaptive confirmatory trial in Japanese patients with palmoplantar pustulosis
BACKGROUND/AIMS: More and more literature describes how to overcome challenges in the implementation of adaptive designs for trials for drug approval process. Most adaptive trials were conducted in Western Europe or USA for Phase II or Phase II/III settings; however, examples of non-oncology pivotal...
Autores principales: | Zheng, Richuan, Ito, Yoichi M., Yunoki, Motonari, Minoda, Kazuki, Nobeyama, Soyoku |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192787/ https://www.ncbi.nlm.nih.gov/pubmed/35711679 http://dx.doi.org/10.1016/j.conctc.2022.100935 |
Ejemplares similares
-
Efficacy and Safety of Guselkumab in Japanese Patients With Palmoplantar Pustulosis: A Phase 3 Randomized Clinical Trial
por: Terui, Tadashi, et al.
Publicado: (2019) -
Guselkumab for the Treatment of Palmoplantar Pustulosis: A Japanese Perspective
por: Yamamoto, Toshiyuki
Publicado: (2021) -
Sustained efficacy and safety of guselkumab in patients with palmoplantar pustulosis through 1.5 years in a randomized phase 3 study
por: Okubo, Yukari, et al.
Publicado: (2021) -
Recent advances in palmoplantar pustulosis
por: Brunasso, Alexandra Maria Giovanna, et al.
Publicado: (2021) -
Palmoplantar pustulosis and IgA nephropathy
por: Shimamura, Yoshinosuke, et al.
Publicado: (2018)